Dr. Ania Jastreboff: The Revolution in Obesity Medication

Howie and Harlan look at the plunging cost of sequencing an individual genome, and the problem of concussions among athletes at all levels. And they’re joined by Dr. Ania Jastreboff, a Yale obesity specialist, to discuss the dramatic results from a new class of drugs that target the brain’s system for regulating body fat. Links: “llumina Unveils Revolutionary NovaSeq X Series to Rapidly Accelerate Genomic Discoveries and Improve Human Health” “The race to a $100 genome” (2013) Ania Jastreboff: “Tirzepatide Once Weekly for the Treatment of Obesity” “FDA Approves New Drug Treatment for Chronic Weight Management, First Since 2014” “NFL under fire over its concussion protocol following Tua Tagovailoa's back-to-back game hits” Learn more about the MBA for Executives program at Yale SOM. Email Howie and Harlan comments or questions.